Baytaş Volkan, Vural Çağıl, Özçelik Menekşe, Torres Rafael Torrejon, Saunders Rhodri, Alkış Neslihan
Department of Anaesthesiology and ICM, Faculty of Medicine, Ankara University, Ankara 06100, Türkiye.
Department of Oral & Maxillofacial Surgery, Anaesthesiology Division, Faculty of Dentistry, Ankara University, Ankara 06100, Türkiye.
J Clin Med. 2023 Sep 14;12(18):5959. doi: 10.3390/jcm12185959.
Endoscopic procedures are routinely applied to cancer screening programs and surveillance. The preferred technique is usually deep sedation with propofol being a convenient agent allowing for a quicker patient recovery while maintaining a similar safety profile compared to traditional agents. However, adverse events, including respiratory depression and consequent undesirable cardiovascular side effects, may occur. The goal of this work is to evaluate the patient safety impact of adding capnography during endoscopic procedures under deep propofol sedation. Data were retrospectively collected from patients undergoing deep, procedural sedation for gastrointestinal (GI) endoscopy in October 2019 to January 2021 in a single Turkish university hospital. Included in the analysis were all adult patients classified by the American Society of Anesthesiologists (ASA) as I-IV, who were scheduled for GI endoscopy utilizing propofol alone or in combination. Data on 1840 patients were collected, of whom 1610 (730 pre- and 880 post-capnography implemention) met inclusion criteria. The primary outcome was a change in the composite incidence of mild oxygen desaturation (SpO 75-90% for <60 s), severe oxygen desaturation (SpO < 75% anytime or <90% for >60 s), bradycardia (<60 ppm), and tachycardia (>25% from baseline). Without capnography, on average, 7.5 events of the primary endpoint were observed per 100 procedures and 2.9 with additional capnography monitoring ( < 0.001). A significant reduction was observed for mild oxygen desaturation, with a resulting odds ratio of 0.25 (95% CI 0.14 to 0.46). ASA I patients had the highest difference in combined incidence of any oxygen desaturation of 5.85% in the pre-capnography group and 0.64% in the post-capnography group. Although procedural sedation using propofol is not associated with severe adverse events, the incidence of composite adverse events could be reduced with the addition of capnography monitoring.
内镜检查程序通常应用于癌症筛查计划和监测。首选技术通常是深度镇静,丙泊酚是一种方便的药物,与传统药物相比,它能使患者更快恢复,同时保持相似的安全性。然而,可能会发生不良事件,包括呼吸抑制以及随之而来的不良心血管副作用。这项工作的目的是评估在丙泊酚深度镇静下的内镜检查过程中增加二氧化碳监测对患者安全性的影响。数据是从2019年10月至2021年1月在土耳其一家大学医院接受胃肠道(GI)内镜检查深度程序镇静的患者中回顾性收集的。纳入分析的是所有被美国麻醉医师协会(ASA)分类为I-IV级的成年患者,他们计划单独使用丙泊酚或联合使用丙泊酚进行GI内镜检查。收集了1840例患者的数据,其中1610例(二氧化碳监测实施前730例,实施后880例)符合纳入标准。主要结局是轻度氧饱和度降低(SpO₂ 75 - 90%持续<60秒)、重度氧饱和度降低(SpO₂随时<75%或<90%持续>60秒)、心动过缓(<60次/分钟)和心动过速(较基线增加>25%)的综合发生率的变化。在没有二氧化碳监测的情况下,每100例手术平均观察到7.5次主要终点事件,而增加二氧化碳监测后为2.9次(P<0.001)。观察到轻度氧饱和度降低有显著减少,得出的比值比为0.25(95%置信区间0.14至0.46)。ASA I级患者在二氧化碳监测前组的任何氧饱和度降低综合发生率与监测后组的差异最大,分别为5.85%和0.64%。虽然使用丙泊酚进行程序镇静与严重不良事件无关,但增加二氧化碳监测可降低综合不良事件的发生率。